Table 3 The laboratory characteristics at baseline of the enrolled patients

LDL–C(mg/dl)

119.2 ± 31.2

120.1 ± 30.2

118.6 ± 32.4

sdLDL–C(mg/dl)

37.9 ± 21.3

43.4 ± 26.5

34.7 ± 20.2

lbLDL–C(mg/dl)

80.4 ± 25.5

75.2 ± 25.4

83.5 ± 25.2

sdLDL–C/LDL–C

0.32 ± 0.13

0.36 ± 0.16

0.29 ± 0.12

TG(mg/dl)

134.5 (91.3–180.5)

132 (87.5–176.3)

135.3 (93.2–185.6)

TC(mg/dl)

190.1 ± 34.9

183.9 ± 30.4

193.8 ± 34.8

HDL–C(mg/dl)

45.7 ± 14.2

42.3 ± 14.8

47.7 ± 13.2

Non-HDL–C(mg/dl)

142.6 ± 33.6

142.8 ± 31.8

142.5 ± 35.4

LDL–C/HDL–C

2.84 ± 1.12

3.11 ± 1.16

2.68 ± 1.06

Apo A-I (mg/dl)

119.0 ± 23.2

111.7 ± 22.7

123.3 ± 22.7

Apo B(mg/dl)

93.0 ± 22.3

95.4 ± 37.3

91.6 ± 20.7

FBG (mg/dl)

116.7 ± 36.2

121.6 ± 37.3

113.8 ± 35.8

HbA1c(%)

6.41 ± 1.23

6.85 ± 1.36

6.15 ± 1.08

hs-CRP (mg/dl)

0.39 (0.16–1.52)

0.53 (0.43–1.65)

0.31 (0.15–1.48)

eGFR(ml/min/1.73 m2)

50.3 ± 16.5

45.6 ± 15.8

53.1 ± 17.7